Simpore Abibou, Bisseye Cyrille, Nagalo Bolni Marius, Sanou Mahamoudou, Nébié Yacoub, Ghoma-Linguissi Laure Stella, Dahourou Honorine, Sawadogo Boukary, Djigma Florencia, Ouattara Siaka, Pietra Virginio, Nichol Jason, Simpore Jacques
Pietro Annigoni Biomolecular Research Center (CERBA)/ (LABIOGENE), University of Ouagadougou, Burkina Faso ; National Blood Transfusion Center, Ouagadougou, Burkina Faso.
Pietro Annigoni Biomolecular Research Center (CERBA)/ (LABIOGENE), University of Ouagadougou, Burkina Faso ; Laboratory of Molecular and Cellular Biology (LABMC), University of Sciences and Techniques of Masuku (USTM), Franceville, Gabon.
Pan Afr Med J. 2014 May 15;18:56. doi: 10.11604/pamj.2014.18.56.3850. eCollection 2014.
Due to the existence of a variety of types of non-venereal syphilis caused by the related T. pallidum, regular serological testing such as Rapid Plasma Reagin (RPR) and Chemiluminescent Microparticle Immunoassay Technique (CMIA) are often unable to differentiate venereal syphilis from the non- venereal one, hence, the interest in the use of molecular biology testing for a confirmation diagnosis of syphilis caused by Treponema pallidum subspecies pallidum.
The study is designed to assess the effectiveness of PCR testing and serological methods in the diagnosis of Treponema pallidum subsp pallidum among blood donors in Burkina Faso.
The study included 6375 samples of volunteer blood donors from the regional blood transfusion center of Ouagadougou (CRTS/O). Among samples, 183 positive and 59 negative in RPR were analyzed to detect antibodies anti-T. pallidum subsp pallidum with a immunoassay method (CMIA) and were confirmed using the Polymerase Chain Reaction testing.
In RPR, we obtained a prevalence rate of 2.9% (183/6375) for treponematosis. From the 183 RPR+ specimen, 108 (59%) were found CMIA+ and 11 (6%) were confirmed PCR+. While the 59 pattern RPR-; 31 (52.5%) were CMIA + including 3 (5.1%) tested PCR+. Seventy-five (75) samples RPR + /CMIA-; 2 (2.7%) were confirmed positive by PCR. All 28 samples RPR-/CMIA- were confirmed negative by PCR.
PCR testing confirmed a low distribution of T. pallidum subsp pallidum in comparison to serological methods. Cross-reactions, existence of non-venereal treponemal or immunological scars could account for the discrepancy between the results obtained.
由于存在多种由相关梅毒螺旋体引起的非性病性梅毒,常规血清学检测如快速血浆反应素试验(RPR)和化学发光微粒子免疫分析技术(CMIA)常常无法区分性病性梅毒和非性病性梅毒,因此,人们对使用分子生物学检测来确诊梅毒螺旋体苍白亚种引起的梅毒产生了兴趣。
本研究旨在评估聚合酶链反应(PCR)检测和血清学方法在布基纳法索献血者中诊断梅毒螺旋体苍白亚种的有效性。
本研究纳入了来自瓦加杜古地区输血中心(CRTS/O)的6375名志愿献血者的样本。在这些样本中,对183份RPR阳性和59份RPR阴性的样本进行分析,采用免疫分析方法(CMIA)检测抗梅毒螺旋体苍白亚种抗体,并通过聚合酶链反应检测进行确诊。
在RPR检测中,梅毒患病率为2.9%(183/6375)。在183份RPR阳性样本中,108份(59%)CMIA阳性,11份(6%)PCR确诊阳性。而59份RPR阴性样本中,31份(52.5%)CMIA阳性,其中3份(5.1%)PCR检测阳性。75份样本RPR阳性/CMIA阴性,2份(2.7%)PCR确诊阳性。所有28份RPR阴性/CMIA阴性样本PCR检测均为阴性。
与血清学方法相比,PCR检测证实梅毒螺旋体苍白亚种的分布较低。交叉反应、非性病性螺旋体的存在或免疫疤痕可能是导致结果差异的原因。